MASTEK NSE filing

Mastek Approves Q1 FY27 Unaudited Financial Results and Amends Insider Trading Code

The RealCase readMedium impact Neutral

Mastek Limited's Board approved Q1 FY27 unaudited financial results. Consolidated net profit stood at ₹10,588 lakhs, and standalone net profit was ₹2,080 lakhs. The company also amended its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.

Why it matters

The approval of quarterly financial results is a material event for investors and stakeholders. The amendment to the insider trading code also has regulatory and governance implications.

The market read

The announcement is a routine disclosure of financial results and an amendment to a corporate policy. While the results are presented, there are no significant positive or negative indicators mentioned in the provided text that would sway the sentiment.

Mastek Limited announced the outcome of its Board Meeting held on July 21, 2026, wherein the Board approved the Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2026. The results were prepared in accordance with Indian Accounting Standards (Ind-AS) and in compliance with SEBI Listing Regulations. The company also approved amendments to its 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information', with the revised code being available on the company's website. The Board meeting commenced at 4:30 PM and concluded at 5:30 PM IST.

The unaudited consolidated financial results for the quarter ended June 30, 2026, show total income of ₹99,728 lakhs and a net profit of ₹10,588 lakhs. For the same period, standalone results indicate total income of ₹22,709 lakhs and a net profit of ₹2,080 lakhs.

The company also published the Limited Review Report issued by M/s. Walker Chandiok & Co. LLP, Statutory Auditors, and stated that an extract of the financial results would be published in newspapers and made available on the company's website. The financial results detail segment revenues from UK & Europe operations, North America operations, and AMEA, with UK & Europe contributing the largest share of revenue.

Filing to action

What to do with a filing like this

Mastek Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Mastek Limited. Read the original for the full detail.

View original filing